Technical Analysis for CNCR - Loncar Cancer Immunotherapy ETF
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 13.42 | -0.07% | -0.01 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Stochastic Buy Signal | Bullish | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Stochastic Buy Signal | Bullish | -0.07% | |
| Lower Bollinger Band Walk | Weakness | -0.07% | |
| Gapped Down | Weakness | -0.07% | |
| Lower Bollinger Band Touch | Weakness | -0.07% | |
| Oversold Stochastic | Weakness | -0.07% |
| Alert | Time |
|---|---|
| Up 1% | 1 day ago |
| Rose Above Lower Bollinger Band | 2 days ago |
| Fell Below Previous Day's Low | 2 days ago |
| Down 1% | 2 days ago |
| Possible Inside Day | 3 days ago |
Free Daily (Stock) Chart Reading
Loncar Cancer Immunotherapy ETF Description
ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.
Classification
Keywords: Exchange Traded Fund ETF Exchange Traded Funds Biotechnology SPDR Cancer Betashares Immune System Immunotherapy Cancer Immunotherapy Biotechnology Sectors Lonca
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Date | Title |
|---|---|
| Oct 31 | F/m Guides Emerald Advisers’ ETF Debut |
| Indicator | Value |
|---|---|
| 52 Week High | 17.9599 |
| 52 Week Low | 10.41 |
| Average Volume | 3,715 |
| 200-Day Moving Average | 15.07 |
| 50-Day Moving Average | 14.95 |
| 20-Day Moving Average | 14.74 |
| 10-Day Moving Average | 14.50 |
| Average True Range | 0.37 |
| RSI (14) | 31.97 |
| ADX | 19.11 |
| +DI | 21.22 |
| -DI | 47.85 |
| Chandelier Exit (Long, 3 ATRs) | 14.84 |
| Chandelier Exit (Short, 3 ATRs) | 14.31 |
| Upper Bollinger Bands | 16.29 |
| Lower Bollinger Band | 13.19 |
| Percent B (%b) | 0.08 |
| BandWidth | 21.07 |
| MACD Line | -0.36 |
| MACD Signal Line | -0.14 |
| MACD Histogram | -0.2281 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 13.74 | ||||
| Resistance 3 (R3) | 13.71 | 13.59 | 13.68 | ||
| Resistance 2 (R2) | 13.59 | 13.51 | 13.60 | 13.66 | |
| Resistance 1 (R1) | 13.50 | 13.46 | 13.44 | 13.53 | 13.65 |
| Pivot Point | 13.38 | 13.38 | 13.35 | 13.39 | 13.38 |
| Support 1 (S1) | 13.29 | 13.30 | 13.23 | 13.32 | 13.19 |
| Support 2 (S2) | 13.17 | 13.25 | 13.18 | 13.18 | |
| Support 3 (S3) | 13.08 | 13.17 | 13.16 | ||
| Support 4 (S4) | 13.11 |
